Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nest.Bio is a life-science venture creation and incubation platform located in Somerville, Massachusetts. Founded in 2018, it provides flexible lab and office space tailored for emerging biotech startups. The organization aims to support pioneering founders in developing, funding, and commercializing innovative technologies within the life sciences sector. Nest.Bio leverages its community resources and infrastructure to facilitate the growth of its portfolio companies.
As of now, Nest.Bio has established itself as a key player in the biotech ecosystem, focusing on early-stage investments and incubation. The firm operates with a commitment to fostering innovation in biotechnology, particularly in therapeutics, synthetic biology, and AI-enabled health technologies. Nest.Bio's strategic location near Kendall Square enhances its access to a vibrant network of biotech talent and resources.
With a portfolio of 40 companies, Nest.Bio has made significant strides in the biotech field. The organization emphasizes collaboration and mentorship, providing essential support to its startups as they navigate the complexities of bringing groundbreaking solutions to market.
Nest.Bio specializes in supporting early-stage biotech companies through a comprehensive approach that includes shared and private lab space, office facilities, and access to a robust network of resources. The firm primarily invests in pre-seed and seed-stage companies, with check sizes ranging from $250,000 to $2 million. Nest.Bio's geographic focus spans North America and Asia, allowing it to bridge opportunities across these regions.
The sectors of interest for Nest.Bio include biotechnology, synthetic biology, and AI-enabled health technologies. The organization is particularly dedicated to fostering innovation in therapeutics and life sciences, working closely with founders to develop, fund, and commercialize their technologies. Nest.Bio's investment thesis revolves around high-impact science, emphasizing the translation of breakthrough biology into innovative therapies.
Founders seeking support can expect Nest.Bio to provide not only capital but also operational support and guidance in navigating funding opportunities and commercialization strategies. This hands-on approach is designed to help biotech ventures thrive in a competitive landscape.
Nest.Bio's portfolio includes a diverse array of companies that are making significant contributions to the biotech field. Notable companies in their portfolio include:
This diverse portfolio showcases Nest.Bio's commitment to advancing biotechnology and supporting innovative solutions that address critical health challenges.
James Weis: Partner and CEO of Nest.Bio Labs and Hatch.Bio Labs, James holds a PhD from MIT and focuses on solving lab infrastructure barriers for biotech teams.
Daphne Teo: Partner and CEO of NSG BioLabs, Daphne plays a crucial role in linking Nest.Bio's initiatives with the biotech ecosystem in Asia.
Xi Chen: Venture Partner, Xi is involved in strategic investment decisions and supports portfolio companies with his expertise.
Samantha Clark: Office Operations Coordinator at Hatch.Bio Labs, Samantha ensures smooth operations within the organization.
Cheryl Cui: Partner and founder, Cheryl is instrumental in life-science venture creation and cross-border company incubation.
Lorena Dai: Involved in investment activities, Lorena contributes to identifying promising biotech ventures.
Hingge Hsu: Partner, Hingge brings valuable insights and expertise to the investment team.
Steven Landau: Venture Partner, Steven supports portfolio companies with strategic guidance.
Jeffrey Lu: Venture Partner, Jeffrey is engaged in investment activities and portfolio management.
Tim Lu: Advisor, Tim provides strategic advice to the Nest.Bio team.
Trevor Schuck: Business Development Director at Hatch.Bio Labs, Trevor focuses on fostering partnerships and collaborations.
Joy Srinivas-Vargas: Site Manager at Hatch.Bio Labs, Joy oversees daily operations and supports resident companies.
To pitch Nest.Bio, founders should reach out via email at info@nest.bio. It is advisable to include a concise overview of the startup, highlighting the innovative technology and its potential impact. Founders should also outline their funding needs and how they plan to utilize the investment.
While there is no formal pitch process disclosed, providing a clear and compelling narrative about the startup's vision and market opportunity can increase the chances of engagement. Founders should be prepared for a rolling application cycle, allowing for flexibility in discussions.
Response times may vary, so patience is encouraged. Warm introductions can be beneficial, but are not strictly necessary for initial outreach.
In April 2026, Nest.Bio hosted the Launch@Hatch Prize Competition, an annual pitch competition and founder showcase aimed at highlighting innovative biotech startups.
In May 2025, Nest.Bio Ventures announced a $39 million Series B financing round for PAQ Therapeutics, a company focused on autophagy-based therapeutics.
In July 2024, Nest.Bio was involved in a licensing agreement between Foreseen and Ipsen, showcasing its active engagement in the biotech community.
Additionally, Nest.Bio has been recognized for its support of MassNextGen awardee Cellens in April 2026, further solidifying its reputation in the biotech sector.
What are Nest.Bio's investment criteria?
Nest.Bio focuses on early-stage biotech companies, particularly in sectors such as therapeutics, synthetic biology, and AI-enabled health technologies. They typically invest in pre-seed and seed stages, with check sizes ranging from $250,000 to $2 million.
How can I apply or pitch to Nest.Bio?
Founders can reach out to Nest.Bio via email at info@nest.bio to initiate discussions about potential investment opportunities. There is no formal pitch process disclosed, but inquiries are welcomed.
What makes Nest.Bio different from other investors?
Nest.Bio distinguishes itself by providing not only capital but also access to essential lab infrastructure and operational support. Their focus on fostering a collaborative community enhances networking opportunities for portfolio companies.
What is Nest.Bio's geographic scope?
The firm primarily focuses on North America and Asia, allowing them to bridge opportunities and support biotech ventures that have cross-border potential.
What kind of post-investment involvement can founders expect?
Nest.Bio is committed to providing ongoing support to its portfolio companies, including guidance in navigating funding opportunities and commercialization strategies. Their hands-on approach helps startups thrive in a competitive landscape.
What is the typical decision timeline for investments?
While specific timelines are not disclosed, Nest.Bio operates on a rolling application cycle, allowing for flexibility in discussions and decisions.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.